Topical Finasteride – Hims and Keeps now offer 2-in-1 Topical Finasteride, which is a less-risky, non-pill way to treat your scalp directly without any chemicals getting into your blood stream.

Hims Topical Finasteride & Minoxidil Spray is created by a process called compounding. Compounded medications are customized or altered to meet a specific need (in this case, mixing two active ...

Hims Topical Finasteride & Minoxidil Spray is created by a process called compounding. Compounded medications are customized or altered to meet a specific need (in this case, mixing two active ...

Hims & Hers Health has called time on Apostrophe, its personalised acne treatments business. The San Francisco-based ...

Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operation | Hims & Hers ...

Shares of Hims & Hers Health (HIMS) tumbled 15% yesterday after Novo Nordisk (NVO) announced it was cutting the price of its GLP-1 weight-loss drug Wegovy by more than half. The move obliterates ...

Hims and Roman are telehealth companies that sell prescription and nonprescription products to treat erectile dysfunction (ED), hair loss, and premature ejaculation (PE). Both ED and hair loss can ...

GQ's own Adam Hurly has subjected his dome to many of Hims' products, leaving his testing with the impression that the topical minoxidil serum might be one of the best offerings. The OTC serum ...

Hims & Hers Health (NYSE:HIMS) shut down Apostrophe on Friday, the skincare business it acquired in 2019 for $190M. A message at the top of Apostrophe's website says, "Apostrophe is being ...

Telehealth stock Hims & Hers (HIMS) spiked more than 24% in ... The stock's move followed the US Senate approval of Robert F. Kennedy Jr. as the new Health and Human Services (HHS) secretary ...

Hims & Hers is shutting down the dermatology business it acquired in 2021, BI has learned. It said it's closing the skincare site Apostrophe to centralize its teledermatology offerings. Hims ...

Plus, Robert F. Kennedy Jr. becoming the head of Health & Human Services, which oversees the FDA, could lead to greater scrutiny of the market. At 12 times sales, HIMS stock is not cheap either ...